Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis Review

Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimally-invasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclairs major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc Key Recent Developments

Apr 30,2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017
Apr 30,2018: Sinclair secures 23 million debt facility
Jan 16,2018: Sinclair Pharma: Ellanse Approved for Brazil
Sep 19,2017: Sinclair Pharma: Interim Results
Jul 11,2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Sinclair Pharma Plc - Key Facts 5
Sinclair Pharma Plc - Key Employees 6
Sinclair Pharma Plc - Key Employee Biographies 7
Sinclair Pharma Plc - Major Products and Services 8
Sinclair Pharma Plc - History 9
Sinclair Pharma Plc - Company Statement 12
Sinclair Pharma Plc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 Company Analysis 16
Sinclair Pharma Plc - Business Description 16
R&D Overview 16
Sinclair Pharma Plc - SWOT Analysis 17
SWOT Analysis - Overview 17
Sinclair Pharma Plc - Strengths 17
Sinclair Pharma Plc - Weaknesses 18
Sinclair Pharma Plc - Opportunities 19
Sinclair Pharma Plc - Threats 20
Sinclair Pharma Plc - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Companys Lifesciences Financial Deals and Alliances 28
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Sinclair Pharma Plc, Recent Deals Summary 30
Section 5 Companys Recent Developments 31
Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 31
Apr 30, 2018: Sinclair secures 23 million debt facility 34
Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil 35
Sep 19, 2017: Sinclair Pharma: Interim Results 36
Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 41
Mar 30, 2017: Sinclair Pharma: Additional listing 42
Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 43
Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 44
Section 6 Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables

List of Tables
Sinclair Pharma Plc, Key Facts 5
Sinclair Pharma Plc, Key Employees 6
Sinclair Pharma Plc, Key Employee Biographies 7
Sinclair Pharma Plc, Major Products and Services 8
Sinclair Pharma Plc, History 9
Sinclair Pharma Plc, Other Locations 14
Sinclair Pharma Plc, Subsidiaries 14
Sinclair Pharma Plc, Key Competitors 21
Sinclair Pharma Plc, Ratios based on current share price 22
Sinclair Pharma Plc, Annual Ratios 23
Sinclair Pharma Plc, Annual Ratios (Cont...1) 24
Sinclair Pharma Plc, Interim Ratios 26
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Sinclair Pharma Plc, Recent Deals Summary 30
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

List Of Figures

List of Figures
Sinclair Pharma Plc, Performance Chart (2013 - 2017) 25
Sinclair Pharma Plc, Ratio Charts 27
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Sinclair Pharma Plc (SPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics,

USD 250 View Report

Sinclair Pharma PLC (SPH) - Product Pipeline Analysis, 2018 Update

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics,

USD 750 View Report

Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development

USD 250 View Report

Midatech Pharma Plc (MTPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The companys products include gelclair, oravig, soltamox and zuplenz. It conducts

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available